554 related articles for article (PubMed ID: 23784881)
1. In vivo targeting of human DC-SIGN drastically enhances CD8⁺ T-cell-mediated protective immunity.
Hesse C; Ginter W; Förg T; Mayer CT; Baru AM; Arnold-Schrauf C; Unger WW; Kalay H; van Kooyk Y; Berod L; Sparwasser T
Eur J Immunol; 2013 Oct; 43(10):2543-53. PubMed ID: 23784881
[TBL] [Abstract][Full Text] [Related]
2. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
3. Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells.
Unger WW; van Beelen AJ; Bruijns SC; Joshi M; Fehres CM; van Bloois L; Verstege MI; Ambrosini M; Kalay H; Nazmi K; Bolscher JG; Hooijberg E; de Gruijl TD; Storm G; van Kooyk Y
J Control Release; 2012 May; 160(1):88-95. PubMed ID: 22366522
[TBL] [Abstract][Full Text] [Related]
4. In vivo targeting of antigens to human dendritic cells through DC-SIGN elicits stimulatory immune responses and inhibits tumor growth in grafted mouse models.
Kretz-Rommel A; Qin F; Dakappagari N; Torensma R; Faas S; Wu D; Bowdish KS
J Immunother; 2007 Oct; 30(7):715-26. PubMed ID: 17893564
[TBL] [Abstract][Full Text] [Related]
5. Targeting dendritic cells with antigen via dendritic cell-associated promoters.
Moulin V; Morgan ME; Eleveld-Trancikova D; Haanen JB; Wielders E; Looman MW; Janssen RA; Figdor CG; Jansen BJ; Adema GJ
Cancer Gene Ther; 2012 May; 19(5):303-11. PubMed ID: 22361816
[TBL] [Abstract][Full Text] [Related]
6. Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation.
van Kooyk Y; Unger WW; Fehres CM; Kalay H; García-Vallejo JJ
Mol Immunol; 2013 Sep; 55(2):143-5. PubMed ID: 23158834
[TBL] [Abstract][Full Text] [Related]
7. Decreased pathology and prolonged survival of human DC-SIGN transgenic mice during mycobacterial infection.
Schaefer M; Reiling N; Fessler C; Stephani J; Taniuchi I; Hatam F; Yildirim AO; Fehrenbach H; Walter K; Ruland J; Wagner H; Ehlers S; Sparwasser T
J Immunol; 2008 May; 180(10):6836-45. PubMed ID: 18453604
[TBL] [Abstract][Full Text] [Related]
8. Targeting
Velasquez LN; Stüve P; Gentilini MV; Swallow M; Bartel J; Lycke NY; Barkan D; Martina M; Lujan HD; Kalay H; van Kooyk Y; Sparwasser TD; Berod L
Front Immunol; 2018; 9():471. PubMed ID: 29662482
[TBL] [Abstract][Full Text] [Related]
9. Lewis X oligosaccharides targeting to DC-SIGN enhanced antigen-specific immune response.
Wang J; Zhang Y; Wei J; Zhang X; Zhang B; Zhu Z; Zou W; Wang Y; Mou Z; Ni B; Wu Y
Immunology; 2007 Jun; 121(2):174-82. PubMed ID: 17371544
[TBL] [Abstract][Full Text] [Related]
10. Mouse DC-SIGN/CD209a as Target for Antigen Delivery and Adaptive Immunity.
Schetters STT; Kruijssen LJW; Crommentuijn MHW; Kalay H; Ochando J; den Haan JMM; Garcia-Vallejo JJ; van Kooyk Y
Front Immunol; 2018; 9():990. PubMed ID: 29867967
[TBL] [Abstract][Full Text] [Related]
11. Antibody-mimetic ligand selected by mRNA display targets DC-SIGN for dendritic cell-directed antigen delivery.
Xiao L; Hung KC; Takahashi TT; Joo KI; Lim M; Roberts RW; Wang P
ACS Chem Biol; 2013 May; 8(5):967-77. PubMed ID: 23427768
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction.
Granelli-Piperno A; Pritsker A; Pack M; Shimeliovich I; Arrighi JF; Park CG; Trumpfheller C; Piguet V; Moran TM; Steinman RM
J Immunol; 2005 Oct; 175(7):4265-73. PubMed ID: 16177066
[TBL] [Abstract][Full Text] [Related]
13. In vivo targeting of porcine reproductive and respiratory syndrome virus antigen through porcine DC-SIGN to dendritic cells elicits antigen-specific CD4T cell immunity in pigs.
Subramaniam S; Piñeyro P; Tian D; Overend C; Yugo DM; Matzinger SR; Rogers AJ; Haac ME; Cao Q; Heffron CL; Catanzaro N; Kenney SP; Huang YW; Opriessnig T; Meng XJ
Vaccine; 2014 Nov; 32(50):6768-75. PubMed ID: 25446829
[TBL] [Abstract][Full Text] [Related]
14. Comparison of antibodies and carbohydrates to target vaccines to human dendritic cells via DC-SIGN.
Cruz LJ; Tacken PJ; Pots JM; Torensma R; Buschow SI; Figdor CG
Biomaterials; 2012 Jun; 33(16):4229-39. PubMed ID: 22410170
[TBL] [Abstract][Full Text] [Related]
15. Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation.
Tacken PJ; Ginter W; Berod L; Cruz LJ; Joosten B; Sparwasser T; Figdor CG; Cambi A
Blood; 2011 Oct; 118(15):4111-9. PubMed ID: 21860028
[TBL] [Abstract][Full Text] [Related]
16. Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells.
Burleigh L; Lozach PY; Schiffer C; Staropoli I; Pezo V; Porrot F; Canque B; Virelizier JL; Arenzana-Seisdedos F; Amara A
J Virol; 2006 Mar; 80(6):2949-57. PubMed ID: 16501104
[TBL] [Abstract][Full Text] [Related]
17. Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.
Fehres CM; Kalay H; Bruijns SC; Musaafir SA; Ambrosini M; van Bloois L; van Vliet SJ; Storm G; Garcia-Vallejo JJ; van Kooyk Y
J Control Release; 2015 Apr; 203():67-76. PubMed ID: 25656175
[TBL] [Abstract][Full Text] [Related]
18. The DC-SIGN of zebrafish: insights into the existence of a CD209 homologue in a lower vertebrate and its involvement in adaptive immunity.
Lin AF; Xiang LX; Wang QL; Dong WR; Gong YF; Shao JZ
J Immunol; 2009 Dec; 183(11):7398-410. PubMed ID: 19890038
[TBL] [Abstract][Full Text] [Related]
19. Activation of human monocyte-derived dendritic cells by Burkholderia pseudomallei does not require binding to the C-type lectin DC-SIGN.
Charoensap J; Engering A; Utaisincharoen P; van Kooyk Y; Sirisinha S
Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S76-81. PubMed ID: 19121694
[TBL] [Abstract][Full Text] [Related]
20. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells.
Arrighi JF; Pion M; Wiznerowicz M; Geijtenbeek TB; Garcia E; Abraham S; Leuba F; Dutoit V; Ducrey-Rundquist O; van Kooyk Y; Trono D; Piguet V
J Virol; 2004 Oct; 78(20):10848-55. PubMed ID: 15452205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
